Kura Oncology is trading 8.47% up now at $13.45 after President and CEO Troy Wilson purchased 100,000 shares for approximately $1.24 million on August 24, 2026, according to regulatory-filing coverage.
- The purchase occurred at a weighted average price of $12.39 per share.
- Reports explicitly linked the buying to the stock’s advance; Wilson made an identical 100,000-share purchase one week earlier.